MCCOMAS, CASEY, C.,KUDUK, SCOTT, D.,REGER, THOMAS, S.
申请号：
EP13856512
公开号：
EP2922543A4
申请日:
2013.11.15
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention is directed to substituted pyridinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntingtons disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
